Patterns of growth and decline in lung function in Persistent Childhood Asthma

New England Journal of Medicine

Volumn 374, Issue 19, 2016, Pages 1842-1852

  McGeachie, M J ^a   Yates, K P ^e   Zhou, X ^a   Guo, F ^a   Sternberg, A L ^e   Van Natta, M L ^e   Wise, R A ^f   Szefler, S J ^g   Sharma, S ^h   Kho, A T ^a,c   Cho, M H ^a   Croteau Chonka, D C ^a   Castaldi, P J ^a   Jain, G ⁱ   Sanyal, A ^i,k   Zhan, Y ⁱ   Lajoie, B R ⁱ   Dekker, J ^i,j   Stamatoyannopoulos, J ^l   Covar, R A ^g,h   Zeiger, R S ⁿ   Adkinson, N F ^f   Williams, P V ^m   Kelly, H W ^o   Grasemann, H ^p   Vonk, J M ^q,r   Koppelman, G H ^q   Postma, D S ^q,r   Raby, B A ^a   Houston, I ^a   Lu, Q ^d   Fuhlbrigge, A L ^a,b   Tantisira, K G ^a   Silverman, E K ^a   Tonascia, J ^e   Weiss, S T ^a   Strunk, R C ^s   more..

^a CHANNING LABORATORY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CHILDREN S HOSPITAL   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ San Diego   (United Kingdom)

^j UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^k NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^l UNIVERSITY OF WASHINGTON   (United States)

^m Northwest Asthma & Allergy Center   (United States)

ⁿ KAISER PERMANENTE   (United States)

^o UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^p UNIVERSITY OF TORONTO   (Canada)

^q UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^r UNIVERSITY OF GRONINGEN   (Netherlands)

^s WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG FUNCTION GROWTH AND DECLINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT ALLERGY; SEX DIFFERENCE; SPIROMETRY; ADOLESCENT; CONTROLLED STUDY; GROWTH, DEVELOPMENT AND AGING; INHALATIONAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; YOUNG ADULT;

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; BUDESONIDE; NEDOCROMIL;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; LUNG; MALE; NEDOCROMIL; RISK FACTORS; SEX FACTORS; SPIROMETRY; YOUNG ADULT;

EID: 84966480721     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1513737     Document Type: Article

References (37)

1. Speizer FE, Tager IB. Epidemiology of chronic mucus hypersecretion and obstructive airways disease. Epidemiol Rev 1979; 1: 124-42.
2. Weiss ST, Speizer FE. Epidemiology and natural history. In: Weiss EB, Stein M, eds. Bronchial asthma: mechanisms and therapeutics. 3rd ed. Boston: Little, Brown, 1993: 15.
3. Fletcher C. The natural history of chronic bronchitis and emphysema: an eight-year study of early chronic obstructive lung disease in working men in London. New York: Oxford University Press, 1976.
4. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-22.
5. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000; 356: 1313-7.
6. Stocks J, Hislop A, Sonnappa S. Early lung development: lifelong effect on respiratory health and disease. Lancet Respir Med 2013; 1: 728-42.
7. Grol MH, Gerritsen J, Vonk JM, et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: a 30-year follow-up study. Am J Respir Crit Care Med 1999; 160: 1830-7.
8. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-200.
9. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171: 109-14.
10. Tantisira KG, Fuhlbrigge AL, Tonascia J, et al. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol 2006; 117: 1264-71.
11. Hallberg J, Anderson M, Wickman M, Svartengren M. Factors in infancy and childhood related to reduced lung function in asthmatic children: a birth cohort study (BAMSE). Pediatr Pulmonol 2010; 45: 341-8.
12. Ulrik CS. Outcome of asthma: longitudinal changes in lung function. Eur Respir J 1999; 13: 904-18.
13. Jamrozik E, Knuiman MW, James A, Divitini M, Musk AW. Risk factors for adult-onset asthma: a 14-year longitudinal study. Respirology 2009; 14: 814-21.
14. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65: 14-20.
15. Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370: 758-64.
16. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials 1999; 20: 91-120.
17. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054-63.
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-87.
19. Cleveland WS. LOWESS: a program for smoothing scatterplots by robust locally weighted regression. Am Stat 1981; 35: 54.
20. Hosmer DW, Lemeshow S, May S. Applied survival analysis: regression modeling of time-to-event data. 2nd ed. Hoboken, NJ: Wiley-Interscience, 2008.
21. Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken, NJ: Wiley, 2013.
22. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-65.
23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
24. Fleiss JL, Levin BA, Paik MC. Statistical methods for rates and proportions. 3rd ed. Hoboken, NJ: Wiley-Interscience, 2003.
25. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-51.
26. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011; 105: 907-15
27. Wang X, Mensinga TT, Schouten JP, Rijcken B, Weiss ST. Determinants of maximally attained level of pulmonary function. Am J Respir Crit Care Med 2004; 169: 941-9.
28. Guerra S, Sherrill DL, Kurzius-Spencer M, et al. The course of persistent airflow limitation in subjects with and without asthma. Respir Med 2008; 102: 1473-82.
29. Hollams EM, de Klerk NH, Holt PG, Sly PD. Persistent effects of maternal smoking during pregnancy on lung function and asthma in adolescents. Am J Respir Crit Care Med 2014; 189: 401-7.
30. Huang S, Vasquez MM, Halonen M, Martinez FD, Guerra S. Asthma, airflow limitation and mortality risk in the general population. Eur Respir J 2015; 45: 338-46.
31. Harmsen L, Ulrik CS, Porsbjerg C, Thomsen SF, Holst C, Backer V. Airway hyperresponsiveness and development of lung function in adolescence and adulthood. Respir Med 2014; 108: 752-7.
32. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322-7.
33. Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 2014; 69: 805-10.
34. Strunk RC, Weiss ST, Yates KP, Tonascia J, Zeiger RS, Szefler SJ. Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol 2006; 118: 1040-7.
35. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-35.
36. Lange P, Celli B, Agustí A, et al. Lungfunction trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015; 373: 111-22.
37. Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med 2012; 106: 319-28.